Navigation Links
Hemochromatosis Patients' Blood is Safe

Blood donors with hemochromatosis, a disorder in which iron accumulates in organs and body tissues, do not pose a greater risk to blood safety than other donors, according to the results of a study funded by the National Heart, Lung, and Blood Institute (NHLBI). //

Hemochromatosis patients are treated with periodic phlebotomies or "blood letting" to remove excess iron from their body. Because these patients benefit medically and financially by giving blood, there has been concern that they might donate despite having infectious disease risk factors and that their blood might be less safe. As a result, FDA regulations have not promoted blood donation from hemochromatosis patients.

"Hemochromatosis patients had no more risk of transmitting viral infections than did other donors. This finding should help guide future decisions on blood donations by these patients. If people with hemochromatosis qualify as donors then that could potentially have a significant impact on the national blood supply," said NHLBI Director Dr. Claude Lenfant. Current FDA regulations for blood donation do not prohibit blood from hemochromatosis patients.


'"/>




Page: 1

Related medicine news :

1. Colon cancer risk linked to genes causing Hemochromatosis
2. Painkillers Do Not Shorten Dying Patients Lives
3. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
4. Doctors Response To Patients Religious Beliefs Can Vary
5. Queensland Health Holding Back Dental Patients HIV Results
6. New Genetic Test Predicts Eye-Cancer Patients Futures
7. Patients Requests for Antidepressants can Influence Physician Evaluation of Depression
8. Recommendations for Treatment of Blood Pressue
9. Blood Cells Capable of Regenerating Liver
10. Blood clots likely in long travel
11. Blood transfusions beneficial after heart attacks
Post Your Comments:
(Date:10/7/2008)...ON, N.J., Oct. 7 /PRNewswire-FirstCall/ -- Majesco...tive provider of video games for the mass,market, ...imatum 2009 has,gone gold and is scheduled to ship...t of its kind to integrate a celebrity fitness tra...d life coach on the popular television,series "The...
(Date:10/7/2008)...ELAND, Oct. 7 /PRNewswire/ -- Cleveland Medical De...d $1.23 million in NIH SBIR,FastTrack funding from...Tune(TM), a system to augment stimulator programmi...Parkinson,s disease (PD). CleveMed is,collaboratin...estoration of,the Cleveland Clinic Foundation, a w...
(Date:10/7/2008)...ENCE, R.I. Researchers from the Bradley Hasbro Ch...g new research today at the National Institute of ... Conference on the Role of Families in Preventing ..., held in Providence, R.I. from October 6-8, drew ...e providers to discuss the most effective approach...
(Date:10/7/2008)... Industrial Specialties, Mfg. is ...nnect in-line filters. These filters are exclusive...designed with John Guest push-to-connect style fit...using. This unique in-line filter offers versatili.... , (PRWEB) October 7, 20...
Breaking Medicine News(10 mins):Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 3Health News:CleveMed Receives $1.23 Million in NIH Funding to Develop a System to Augment Deep Brain Stimulation Programming in Parkinson's Disease 2Health News:New research on family-based HIV prevention presented at annual NIH conference 2Health News:New research on family-based HIV prevention presented at annual NIH conference 3
...uct recall in US without a Chinese link. Following...e manufactured in a Georgia facility are being wit...ulism from commercially canned foods in nearly fou...cials asked consumers and stores to discard 10-oun...
...rted left-handers, natural lefties who have switch...hift changes the way their brains are organized, ...chers say while some areas in such peoples brains ...aracteristics of a practising lefty, other areas s...
...e in the number of Australian HIV cases in the pas...sexual behaviour in men having sex with men, and s...arting to emerge, according to research published ...stralia. Professor John Kaldor, Deputy Director a...
...ief executive, James Mullen is not a happy man. Th... receive approval from European regulators to use ...isease, a debilitating intestinal ailment. Resul...an application to the European Medicines Agency we...
Other Medicine News:Health News:Chilly Sauce Linked to Botulism, Forcing Recall in US 2Health News:Chilly Sauce Linked to Botulism, Forcing Recall in US 3Health News:Converting Left-hander to Right-hander also Changes the Brain 2Health News:HIV Cases Increasing In Australia 2Health News:MS Drug Fails The Test For Treating Crohns Disease 2
(Date:10/7/2008)...E, Mass., Oct. 7 /- Taligen Therapeut...ral of the Company,s pipeline,candidates were pres...p in,Basel, Switzerland. The data highlighted the ...omplement-mediated diseases., "These highlighted ...,presented at the conference, reveal the deep expe...
(Date:10/7/2008)... Prospective Randomized Placebo-Controlled Phase I...mproved Overall Survival., MOUNTAIN VIEW, Califor...cs has now evaluated the mature Phase II data from... PROSTVAC(TM) that had been,obtained as part of th...ancer Institute (NCI) in the US., The results fro...
(Date:10/7/2008)... Expanded to Eight On-Demand Tests for Use on the ...m, SUNNYVALE, Calif., Oct. 7 /PRNewswire-FirstCal...elease of Xpert(TM) vanA/vanB as a European CE,IVD...itro Diagnostic,Medical Devices. The test delivers...nes most commonly associated with vancomycin-resis...
(Date:10/6/2008)...N, N.J., Oct. 6 /- Pharmass....T. Smith, Ph.D., is joining the,Company as Vice P...nications. Dr. Smith will be responsible for all i...ly to Chief Financial Officer Kurt,Leutzinger., M...enior Biotechnology,Analyst at JPMorgan Securities...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Temporary Amnesia Confusion Raise Stroke Dementia Risk 8812 1Temporary Amnesia Confusion Raise Stroke Dementia Risk 8812 2Temporary Amnesia Confusion Raise Stroke Dementia Risk 8812 3Medifast Inc Director of Research 26 Development Co Authors Health Book 8809 1Medifast Inc Director of Research 26 Development Co Authors Health Book 8809 2Medifast Inc Director of Research 26 Development Co Authors Health Book 8809 3Medifast Inc Director of Research 26 Development Co Authors Health Book 8809 4Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center 8806 1Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center 8806 2Class of Chemotherapy Drugs Helps Certain Breast Cancer Patients 8803 1Class of Chemotherapy Drugs Helps Certain Breast Cancer Patients 8803 2Class of Chemotherapy Drugs Helps Certain Breast Cancer Patients 8803 3
...ACH TIKVA, Israel--(BUSINESS WIRE)--Jun 14, 2007 -...ompany traded on the Tel,Aviv Stock Exchange Excha...ug CF502; this is in addition to CF101, which is c... preclinical phases. This,weekend Can-Fite will pr... in-vitro and in vivo study results showing effect...
... YORK--(BUSINESS WIRE)--Jun 14, 2007 - Pluristem L...erapeutics Company dedicated,to the commercializat...rative and auto-immune indications, announced toda...ave been demonstrated in,vitro to have properties ...tential to treat Parkinson,s Disease (PD). PLX cel...
Other Medicine Technology:Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 2Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 3Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 4
...esorbable implant that is used for covering trephi...ry, user-friendly design, shaped like a flattened ... and requires no fixation by screws, unlike titani... the scaffold architecture minimizes potential inj...
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite.
Safe-Wrap tubes are heparinized glass capillary devices wrapped in a puncture-resistant film. These tubes are used for the collection of capillary blood samples for the measurement of pH, blood gases
...plant is a sterile off white, moist, tough but fle... its constituent elastin fibres presented moist in...eady to use in double vacuum packed aluminium foil...gen, and is sterilised by gamma irradiation. Porci...
Medicine Products: